Beauty salon

Sotera Health Reports Second-Quarter and First-Half 2023 Results

Retrieved on: 
Thursday, August 3, 2023
Capital expenditure, Bank statement, Disclosure, Health, Segment, SHC, GAAP, EBITDA, Acquisition, Net income, Petras, Capital, Webcast, Depreciation, Growth, EPS, Ethylene oxide, EO, Environment, Beauty salon, Financial services, Rare-earth element, Video game, Cryptocurrency, Bank, Retail, Bookkeeping, Real estate, Nordion, Adjustment

Second-quarter 2023 Adjusted Earnings Per Diluted Share (“Adjusted EPS”) was $0.21, compared to $0.27 in the second quarter of 2022.

Key Points: 
  • Second-quarter 2023 Adjusted Earnings Per Diluted Share (“Adjusted EPS”) was $0.21, compared to $0.27 in the second quarter of 2022.
  • Updates on recent developments in matters relevant to investors can be found on the Investor Relations section of the Sotera Health website at Investor Relations | Sotera Health .
  • Unless expressly indicated or the context requires otherwise, the terms “Sotera Health,” “Company,” “we,” “us,” and “our” in this document refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis.
  • These results should be considered in addition to, not as a substitute for, results reported in accordance with GAAP.

Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

Retrieved on: 
Thursday, August 3, 2023
Central nervous system, Therapy, SG, DSM-IV codes, Prescription, MADRS, CNS, MDD, Patient, Growth, R, DSM-5, Research, Psychiatry, Total, Beauty salon, Pharmaceutical industry, Video game, Medical device

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced its financial results for the second quarter ended June 30, 2023 and provided a corporate update.

Key Points: 
  • Cost of product sales was $7.2 million in the second quarter of 2023 compared to $4.7 million for the same period in 2022.
  • Research and development (R&D) expenses were $49.8 million for the second quarter of 2023, compared to $38.5 million for the same period in 2022.
  • Full year 2023 CAPLYTA net product sales guidance increased to $445 to $465 million from the previous range of $430 to $455 million.
  • Full year 2023 SG&A expense guidance of $420 to $450 million and R&D expense guidance of $195 to $220 million reiterated.

Bruker Reports Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 3, 2023
Professional Services, Finance, BSI, FY, BRKR, Table, Telephone, Bruker, GAAP, Proteomics, BEST, Corporation, Investment, Growth, Webcast, EPS, Conference, Cryptocurrency, Video game, Beauty salon, Natural gas, Bank, Pharmaceutical industry

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2023.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2023.
  • Bruker’s second quarter 2023 non-GAAP operating margin was 15.3%, down 130 basis points from 16.6% in the second quarter of 2022.
  • Second quarter 2023 GAAP diluted earnings per share (EPS) were $0.39, compared to $0.33 in the second quarter of 2022.
  • Second quarter 2023 non-GAAP diluted EPS were $0.50, an increase of 11.1% compared to $0.45 in the second quarter of 2022.

Lamar Advertising Company Announces Second Quarter Ended June 30, 2023 Operating Results

Retrieved on: 
Thursday, August 3, 2023
FFO, Lamar, EBITDA, Acquisition, GAAP, Account, Beauty salon, Cryptocurrency

BATON ROUGE, La., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Lamar Advertising Company (the “Company” or “Lamar”) (Nasdaq: LAMR), a leading owner and operator of outdoor advertising and logo sign displays, announces the Company’s operating results for the second quarter ended June 30, 2023.

Key Points: 
  • Adjusted EBITDA for the second quarter of 2023 was $253.9 million versus $243.4 million for the second quarter of 2022, an increase of 4.3%.
  • Cash flow provided by operating activities was $198.2 million for the three months ended June 30, 2023 versus $210.6 million for the second quarter of 2022, a decrease of $12.4 million.
  • Acquisition-adjusted net revenue for the second quarter of 2023 increased 2.7% over acquisition-adjusted net revenue for the second quarter of 2022.
  • Acquisition-adjusted EBITDA for the second quarter of 2023 increased 2.9% as compared to acquisition-adjusted EBITDA for the second quarter of 2022.

EQS-News: 1&1 AG: 1&1 with a good first half-year, forecast for 2023 confirmed

Retrieved on: 
Thursday, August 3, 2023
ISIN, Montabaur, Growth, Tax, Depreciation, EPS, AG, Investment, EBIT, Rare-earth element, Video game, Beauty salon, EBITDA

1&1 AG: 1&1 with a good first half-year, forecast for 2023 confirmed

Key Points: 
  • 1&1 AG: 1&1 with a good first half-year, forecast for 2023 confirmed
    The issuer is solely responsible for the content of this announcement.
  • Revenue in H1 2023 rose by 2.1 percent to €1,993.1 million (H1 2022: €1,952.0 million).
  • The increase resulted mainly from higher hardware sales, while service revenue increased by 0.2 percent to €1,584.6 million (H1 2022: €1,581.9 million).
  • €250 million).

ISC Reports 2023 Second Quarter Financial Results

Retrieved on: 
Thursday, August 3, 2023
Bank statement, Audit committee, Disclosure, ISC, PIN, EBITDA, Bank, Acquisition, Wellness Corporate Solutions, Investment, MSA, MD, Veolia Water Technologies & Solutions, Webcast, News, Bookkeeping, Cryptocurrency, Beauty salon, Video game, Pharmaceutical industry, Lithium

Refer to section 2 “Consolidated Financial Analysis” in the MD&A for a reconciliation of adjusted net income and adjusted EBITDA to net income.

Key Points: 
  • Refer to section 2 “Consolidated Financial Analysis” in the MD&A for a reconciliation of adjusted net income and adjusted EBITDA to net income.
  • 2During the second quarter of 2023, ISC has made the decision to add adjusted net income and adjusted free cash flow as new non-IFRS financial metrics that exclude certain items outside the normal course of business and are believed to provide useful information related to ISC’s performance.
  • Refer to “Caution Regarding Forward-Looking Information” in Management’s Discussion & Analysis for the three and six months ended June 30, 2023.
  • This news release provides a general summary of ISC’s results for the quarters ended June 30, 2023, and 2022.

Ormat Technologies Reports Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Insurance, Ormat Technologies, Electricity, GW, PJM, PTC, Policy, PTC (software company), BI, IRA, Sale, Plant, Inflation, EBITDA, Acquisition, Energy storage, Webcast, Geothermal energy, Power purchase agreement, Growth, EPS, Inflation Reduction Act of 2022, ITC, CD4, Adjustment, PPA, Economics, EGL, Renewable energy, Retail, Video game, Beauty salon, Property management, Bookkeeping

RENO, Nev., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA), a leading renewable energy company, today announced financial results for the second quarter ended June 30, 2023.

Key Points: 
  • “During the second quarter, we made significant progress in expanding our operations across our segments, adding approximately 100 MW of total capacity in geothermal, solar, and storage assets throughout the quarter.
  • Product segment revenues increased 222.0% for the second quarter of 2023, compared to 2022, supported by a higher backlog and timing of recognized revenues.
  • Energy Storage segment revenues decreased by 19.7% for the second quarter of 2023, compared to 2022, primarily due to lower energy rates at the PJM compared to the strong commodity price-driven rates in last year’s second quarter.
  • Ormat will host a conference call to discuss its financial results and other matters discussed in this press release on Thursday, August 3, 2023, at 10:00 a.m.

Glaukos Announces Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Medical Devices, Health, Health Technology, Pharmaceutical, Optical, Biotechnology, GKOS, Glaucoma, IPR, SG, GAAP, Retina, Corporation, Standard of care, Patient, Investment, Webcast, EPS, R, Conference, NYSE, Beauty salon, Clothing, Video game, Bank

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023.

Key Points: 
  • Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2023.
  • “Our record second quarter results highlighted by double-digit topline growth reflect the successful execution of our commercial strategies thus far in 2023,” said Thomas Burns, Glaukos chairman and chief executive officer.
  • Loss from operations in the second quarter of 2023 was $29.1 million, compared to operating loss of $36.8 million in the second quarter of 2022.
  • Non-GAAP loss from operations in the second quarter of 2023 was $22.8 million, compared to non-GAAP operating loss of $30.4 million in the second quarter of 2022.

DoorDash Releases Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Technology, Retail, Delivery Services, Other Technology, Total order, Growth, Partnership, Y/Y, HMS Dasher (D37), Free cash flow, EBITDA, Acquisition, GAAP, Research, Marketing, Cardboard, Beauty salon, Wolt, Dasher, BAE Systems Platforms & Services

The cumulative impact of these improvements, along with effective execution and durable end markets, drove strong growth and improved efficiency in Q2 2023.

Key Points: 
  • The cumulative impact of these improvements, along with effective execution and durable end markets, drove strong growth and improved efficiency in Q2 2023.
  • On a reported basis in Q2 2023, we drove Total Orders up 25% Y/Y, Marketplace GOV up 26% Y/Y, and revenue up 33% Y/Y.
  • On a pro forma basis in Q2 2023, including the results from Wolt for both periods, we drove Total Orders up 18% Y/Y, Marketplace GOV up 20% Y/Y, and revenue up 27% Y/Y.
  • Our consumer cohorts performed well in Q2 2023, which contributed to strong Y/Y growth in MAU and drove order frequency to a new all-time high.

Procore Announces Second Quarter 2023 Financial Results

Retrieved on: 
Wednesday, August 2, 2023
Software, Technology, Other Construction & Property, Construction & Property, Partnership, Construction, Table, Mitsubishi B1M, GAAP, Central Time, Groundbreaking, Interest, Pacific Time Zone, Webcast, CFO, Growth, Mental health, Conference, NYSE, Cryptocurrency, Video game, Commercial property, Beauty salon, Procore

Procore Technologies, Inc. (NYSE: PCOR), a leading global provider of construction management software, today announced financial results for the second quarter ended June 30, 2023.

Key Points: 
  • Procore Technologies, Inc. (NYSE: PCOR), a leading global provider of construction management software, today announced financial results for the second quarter ended June 30, 2023.
  • We look forward to sharing more at our upcoming Investor Day.”
    Second Quarter 2023 Financial Highlights:
    Revenue was $229 million, an increase of 33% year-over-year.
  • Procore Technologies, Inc. will hold a conference call to discuss its second quarter results at 2:00 p.m., Pacific Time, on Wednesday, August 2, 2023.
  • Procore Technologies, Inc. will host its 2023 Investor Day on Wednesday, September 20, 2023 from 9:00 a.m. to 12:00 p.m., Central Time.